Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICI-VPH: 2 vs 3 Doses of Gardasil
NCT02009800Phase 3Completed
- Sponsor
- CHU de Québec-Université Laval
- Start
- Nov 2013
- Primary completion
- Dec 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of qHPV vaccine in human papillomavirus infection, sponsored by CHU de Québec-Université Laval. Started Nov 2013; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT02009800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02009800.